342 related articles for article (PubMed ID: 14764897)
41. Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice.
Tang H; Liao Y; Xu L; Zhang C; Liu Z; Deng Y; Jiang Z; Fu S; Chen Z; Zhou S
Int J Cancer; 2013 Nov; 133(10):2473-82. PubMed ID: 23649836
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.
Neumann C; Zehentmaier G; Danhauser-Riedl S; Emmerich B; Hallek M
Eur J Immunol; 1996 Feb; 26(2):379-84. PubMed ID: 8617307
[TBL] [Abstract][Full Text] [Related]
43. Shc mediates ligand-induced internalization of epidermal growth factor receptors.
Sakaguchi K; Okabayashi Y; Kasuga M
Biochem Biophys Res Commun; 2001 Apr; 282(5):1154-60. PubMed ID: 11302736
[TBL] [Abstract][Full Text] [Related]
44. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
45. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells.
Kuribayashi A; Kataoka K; Kurabayashi T; Miura M
Endocrinology; 2004 Nov; 145(11):4976-84. PubMed ID: 15271882
[TBL] [Abstract][Full Text] [Related]
46. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
47. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
Smit L; van der Horst G; Borst J
Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
[TBL] [Abstract][Full Text] [Related]
48. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
Zheng WH; Quirion R
J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
[TBL] [Abstract][Full Text] [Related]
49. B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation.
Lankester AC; van Schijndel GM; Rood PM; Verhoeven AJ; van Lier RA
Eur J Immunol; 1994 Nov; 24(11):2818-25. PubMed ID: 7525306
[TBL] [Abstract][Full Text] [Related]
50. Growth factors change nuclear distribution of estrogen receptor-alpha via mitogen-activated protein kinase or phosphatidylinositol 3-kinase cascade in a human breast cancer cell line.
Takahashi T; Ohmichi M; Kawagoe J; Ohshima C; Doshida M; Ohta T; Saitoh M; Mori-Abe A; Du B; Igarashi H; Takahashi K; Kurachi H
Endocrinology; 2005 Sep; 146(9):4082-9. PubMed ID: 15947004
[TBL] [Abstract][Full Text] [Related]
51. The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.
Choucair A; Pham TH; Omarjee S; Jacquemetton J; Kassem L; Trédan O; Rambaud J; Marangoni E; Corbo L; Treilleux I; Le Romancer M
Oncogene; 2019 May; 38(21):4015-4027. PubMed ID: 30692633
[TBL] [Abstract][Full Text] [Related]
52. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
53. Ticking fast or ticking slow, through Shc must you go?
Martin FM; Friedman JS
Sci Aging Knowledge Environ; 2004 Aug; 2004(32):pe32. PubMed ID: 15308771
[TBL] [Abstract][Full Text] [Related]
54. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
[TBL] [Abstract][Full Text] [Related]
55. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
56. Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERα in human breast cancer MCF-7 cells.
Wang LM; Xie KP; Huo HN; Shang F; Zou W; Xie MJ
Asian Pac J Cancer Prev; 2012; 13(4):1431-7. PubMed ID: 22799344
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptor-mediated activation of the serum response element in MCF-7 cells through MAPK-dependent phosphorylation of Elk-1.
Duan R; Xie W; Burghardt RC; Safe S
J Biol Chem; 2001 Apr; 276(15):11590-8. PubMed ID: 11145955
[TBL] [Abstract][Full Text] [Related]
58. Estrogen rapid action via protein complex formation involving ERalpha and Src.
Song RX; Zhang Z; Santen RJ
Trends Endocrinol Metab; 2005 Oct; 16(8):347-53. PubMed ID: 16126407
[TBL] [Abstract][Full Text] [Related]
59. Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells.
Carloni V; Mazzocca A; Ravichandran KS
Oncogene; 2004 Feb; 23(8):1566-74. PubMed ID: 14676841
[TBL] [Abstract][Full Text] [Related]
60. Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer.
Santen RJ; Song RX; Zhang Z; Yue W; Kumar R
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):337S-45S. PubMed ID: 14734489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
